Should You Buy West Pharmaceutical Services Inc. (WST) Stock After it Has Gained 2.18% in a Week?

Overall market sentiment has been high on West Pharmaceutical Services Inc. (WST) stock lately. WST receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

West Pharmaceutical Services Inc. has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on WST!

See Full WST Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With WST Stock Today?

West Pharmaceutical Services Inc. (WST) stock is trading at $353.51 as of 2:11 PM on Wednesday, Nov 22, an increase of $1.02, or 0.29% from the previous closing price of $352.49. Volume today is light. So far 241,011 shares have traded compared to average volume of 447,162 shares. The stock has traded between $353.24 and $358.49 so far today.

More About West Pharmaceutical Services Inc.

West Pharmaceutical Services is a Pennsylvania-based medical supplies company that operates as a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West develops, manufactures, and distributes elastomer-based supplies for the containment and administration of injectable drugs, including basic equipment such as syringes, stoppers, and plungers, along with somewhat more complicated devices including auto-injectors and other self-injection platforms. The company reports in two segments: proprietary products (82% of 2021 sales) and contract-manufactured products (18%). It generates 55% of its revenue from international markets and 45% from the United States. Click Here to get the full Stock Report for West Pharmaceutical Services Inc. stock.